| 1 |
Lakshminarasimhan A. High-specific activity variants of recombinant human α-glucosidase for the treatment of Pompe disease. Medical Hypotheses 2023. [DOI: 10.1016/j.mehy.2023.111044] [Reference Citation Analysis]
|
| 2 |
Nilsson MI, Crozier M, Di Carlo A, Xhuti D, Manta K, Roik LJ, Bujak AL, Nederveen JP, Tarnopolsky MG, Hettinga B, Meena NK, Raben N, Tarnopolsky MA. Nutritional co-therapy with 1,3-butanediol and multi-ingredient antioxidants enhances autophagic clearance in Pompe disease. Mol Genet Metab 2022:S1096-7192(22)00337-7. [PMID: 35718712 DOI: 10.1016/j.ymgme.2022.06.001] [Reference Citation Analysis]
|
| 3 |
Bhatnagar C, Shah J, Ramani B, Surampalli A, Avanti M, Radom-aizik S, Knight M, Weiss L, Caiozzo V, Kimonis V. Safety and effectiveness of resistance training in patients with late onset Pompe disease - A pilot study. Neuromuscular Disorders 2022. [DOI: 10.1016/j.nmd.2022.02.002] [Reference Citation Analysis]
|
| 4 |
Gutschmidt K, Musumeci O, Díaz-Manera J, Chien YH, Knop KC, Wenninger S, Montagnese F, Pugliese A, Tavilla G, Alonso-Pérez J, Hwu PW, Toscano A, Schoser B. STIG study: real-world data of long-term outcomes of adults with Pompe disease under enzyme replacement therapy with alglucosidase alfa. J Neurol 2021;268:2482-92. [PMID: 33543425 DOI: 10.1007/s00415-021-10409-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 5 |
Terzis G, Papadimas G, Krase A, Kontou E, Arnaoutis I, Papadopoulos C. Body composition and 6 minute walking ability in late-onset pompe disease patients after 9 years of enzyme replacement therapy. Int J Neurosci 2020;:1-7. [PMID: 33045893 DOI: 10.1080/00207454.2020.1835902] [Reference Citation Analysis]
|
| 6 |
Sans MD, Crozier SJ, Vogel NL, D'Alecy LG, Williams JA. Dietary Protein and Amino Acid Deficiency Inhibit Pancreatic Digestive Enzyme mRNA Translation by Multiple Mechanisms. Cell Mol Gastroenterol Hepatol 2021;11:99-115. [PMID: 32735995 DOI: 10.1016/j.jcmgh.2020.07.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 7 |
Wang RY. A Newborn Screening, Presymptomatically Identified Infant With Late-Onset Pompe Disease: Case Report, Parental Experience, and Recommendations. Int J Neonatal Screen 2020;6:22. [PMID: 33073019 DOI: 10.3390/ijns6010022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
